SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-021982
Filing Date
2024-03-13
Accepted
2024-03-13 08:10:29
Documents
96
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2023_protarathera.htm   iXBRL 10-K 1509362
2 LIST OF SUBSIDIARIES f10k2023ex21-1_protarathera.htm EX-21.1 3776
3 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2023ex23-1_protarathera.htm EX-23.1 4535
4 CERTIFICATION f10k2023ex31-1_protarathera.htm EX-31.1 11210
5 CERTIFICATION f10k2023ex31-2_protarathera.htm EX-31.2 11217
6 CERTIFICATION f10k2023ex32-1_protarathera.htm EX-32.1 5825
7 EXECUTIVE COMPENSATION CLAWBACK POLICY f10k2023ex97-1_protarathera.htm EX-97.1 30192
8 GRAPHIC img_001.jpg GRAPHIC 67951
9 GRAPHIC img_002.jpg GRAPHIC 67707
10 GRAPHIC img_003.jpg GRAPHIC 86982
  Complete submission text file 0001213900-24-021982.txt   7502913

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE tara-20231231.xsd EX-101.SCH 70665
12 XBRL CALCULATION FILE tara-20231231_cal.xml EX-101.CAL 29539
13 XBRL DEFINITION FILE tara-20231231_def.xml EX-101.DEF 320714
14 XBRL LABEL FILE tara-20231231_lab.xml EX-101.LAB 558790
15 XBRL PRESENTATION FILE tara-20231231_pre.xml EX-101.PRE 319395
98 EXTRACTED XBRL INSTANCE DOCUMENT f10k2023_protarathera_htm.xml XML 724190
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36694 | Film No.: 24744639
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)